Form 8-K - Current report:
SEC Accession No. 0001193125-22-282630
Filing Date
2022-11-10
Accepted
2022-11-10 16:17:45
Documents
13
Period of Report
2022-11-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d752591d8k.htm   iXBRL 8-K 35250
  Complete submission text file 0001193125-22-282630.txt   197707

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20221109.xsd EX-101.SCH 3221
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20221109_def.xml EX-101.DEF 14223
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20221109_lab.xml EX-101.LAB 23456
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20221109_pre.xml EX-101.PRE 15141
7 EXTRACTED XBRL INSTANCE DOCUMENT d752591d8k_htm.xml XML 5197
Mailing Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446
Business Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 221377484
SIC: 2834 Pharmaceutical Preparations